COMMUNIQUÉS West-GlobeNewswire

Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting
17/04/2018
BERKELEY, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that data from three of the company’s programs were presented at the American Association for Cancer Research ( [...]
Nature's No. 1 Sustainably – strategy update
17/04/2018
Company announcement No. 08 / 2018 Attachment No 08 Natures no1 sustainably
INNATE PHARMA : Promising anti-tumor activity of monalizumab with cetuximab in SCCHN
17/04/2018
preliminary data suggest promising anti-tumor activity of the combination of monalizumab and cetuximab in patients with platinum pretreated SCCHN 8 partial responses (PR) among 26 patients evaluable for efficacy - [...]
INNATE PHARMA : Données préliminaires d'activité prometteuses pour la combinaison monalizumab et cetuximab dans le SCCHN
17/04/2018
DONNÉES PRÉLIMINAIRES D'ACTIVITÉ PROMETTEUSES POUR LA COMBINAISON DE MONALIZUMAB ET CETUXIMAB CHEZ DES PATIENTS ATTEINTS D'UN CANCER DE LA TÊTE ET DE COU ET PRÉTRAITÉS PAR SELS DE PLATINE Huit réponses partielles (PR) [...]
AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway
17/04/2018
AACR ANNUAL MEETING 2018: NANOBIOTIX PRESENTED PRECLINICAL DATA SHOWING NBTXR3 NANOPARTICLES CAN ACTIVATE THE cGAS-STING PATHWAY Paris, France and Cambridge, Massachusetts, April 17, 2018 - NANOBIOTIX (Euronext: NANO - [...]
AACR annual meeting 2018: Nanobiotix a presenté des données précliniques montrant que les nanoparticules NBTXR3 peuvent activer la voie cGAS-STING
17/04/2018
AACR ANNUAL MEETING 2018: NANOBIOTIX A PRESENTE DES DONNEES PRECLINIQUES MONTRANT QUE LES NANOPARTICULES NBTXR3 PEUVENT ACTIVER LA VOIE cGAS-STING Paris, France et Cambridge, Massachusetts, USA, 17 avril, 2018 - [...]
Aptose Presents Preclinical Data on APTO-253 at 2018 AACR Annual Meeting
17/04/2018
Cancer cells deficient in BRCA1 or BRCA2 function hyper-sensitive to APTO-253 CHICAGO and SAN DIEGO and TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS ) today announced the [...]
Durham College and GrowWise Health partner to develop Cannabis Industry Specialization certificate
17/04/2018
First-of-its-kind program will prepare business professionals to join Canada’s cannabis industry OSHAWA, Ontario, April 17, 2018 (GLOBE NEWSWIRE) -- Durham College (DC) and Emblem Corp. (TSXV:EMC) (EMC.WT) (Emblem), on [...]
Ultragenyx and Kyowa Kirin Announce FDA Approval of Crysvita® (burosumab-twza) for the Treatment of Children and Adults with X–Linked Hypophosphatemia (XLH)
17/04/2018
First Approved Therapy for XLH in the U.S. ; Only Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease Ultragenyx to Host Conference Call Today at 4:30 pm Eastern Time NOVATO, Calif. [...]
Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018
17/04/2018
Detailed Characterization of Unique DolaLock Technology Enhancements to Drug Efficacy and Tolerability XMT-1522 Demonstrates Synergy in Combination with a Checkpoint Inhibitor CAMBRIDGE, Mass., April 17, 2018 (GLOBE [...]
Bavarian Nordic A/S - Report on the Results of the Annual General Meeting, held April 17, 2018
17/04/2018
COPENHAGEN, Denmark, April 17, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held the Annual General Meeting with the results as follows: The Annual Report for 2017 was adopted. The Board of Directors' [...]
Annual General Meeting 2018: Tecan shareholders endorse all motions proposed by the Board of Directors
17/04/2018
Increase in the dividend from CHF 1.75 to CHF 2.00 per share Lukas Braunschweiler and Daniel R. Marshak elected as new members of the Board of Directors Lukas Braunschweiler elected as new Chairman of Tecan Heinrich [...]
Diaxonhit et Vatel Direct annoncent une levée de fonds obligataire d'un montant de 2,5 millions d'euros
17/04/2018
Diaxonhit et Vatel Direct annoncent une levée de fonds obligataire de 2,5 millions d'euros Vatel Direct clôture avec succès sa 9 ème levée de fonds en récoltant 2 499 947,44 € Paris, le 17 avril 2018 - Diaxonhit ( [...]
Olainfarm’s Sales in March Exceed 10 Million Euros.
17/04/2018
17 th April, 2018 Olainfarm’s Sales in March Exceed 10 Million Euros. Preliminary three months consolidated sales results show 13% sales increase. Consolidated sales in March Preliminary consolidated results of AS [...]
Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization Spheres
17/04/2018
Product Line Offers Unique, Resorbable Option for Patients with Hypervascular Tumors DUBLIN - April 17, 2018 - Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a [...]
Progressive Care Begins to Take Action to Combat Naked Short Sellers
17/04/2018
MIAMI, April 17, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced that it is beginning the process of combatting naked short selling of the Company’s [...]
Legally Blind Teen Can See Again, And Is Helping Visually Impaired Children See their Mothers For The First Time this Mother’s Day
17/04/2018
A visually impaired 14-year-old will help children living with vision loss see again TORONTO and REDWOOD CITY, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Joel Gomez, a 14-year-old boy born with legal blindness, can now [...]
Family experience survey in Alberta provides voice for quality improvement in long-term care
17/04/2018
CALGARY, Alberta, April 17, 2018 (GLOBE NEWSWIRE) -- The Health Quality Council of Alberta (HQCA) today released results of a 2017 survey of family experiences with long-term care facilities across Alberta. The Long- [...]
ASLAN Pharmaceuticals Announces Presentation of New Pre-Clinical Data on Varlitinib in Hepatocellular Carcinoma at AACR
17/04/2018
SINGAPORE, April 17, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]

Pages